Immunization with Single-Cycle SIV Significantly Reduces Viral Loads After an Intravenous Challenge with SIVmac239
暂无分享,去创建一个
K. Mansfield | L. Picker | J. Lifson | M. Piatak | B. Richardson | B. Jia | Wenjun Li | E. Yuste | David T. Evans | A. Carville | M. DeGottardi | Sharon K. Ng | David T. Evans | M. Quinn Degottardi | S. K. Ng
[1] Jon Cohen. Thumbs Down on Expensive, Hotly Debated Trial of NIH AIDS Vaccine , 2008, Science.
[2] S. Hammer,et al. HIV Vaccine Research: The Way Forward , 2008, Science.
[3] John P. Moore,et al. Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans , 2008, Nature Medicine.
[4] R. Desrosiers,et al. Vaccine Protection by Live, Attenuated Simian Immunodeficiency Virus in the Absence of High-Titer Antibody Responses and High-Frequency Cellular Immune Responses Measurable in the Periphery , 2008, Journal of Virology.
[5] R. Sékaly. The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? , 2008, The Journal of experimental medicine.
[6] R. Steinbrook. One step forward, two steps back--will there ever be an AIDS vaccine? , 2007, The New England journal of medicine.
[7] J. Lifson,et al. Comparison of Plasma Viremia and Antibody Responses in Macaques Inoculated with Envelope Variants of Single-Cycle Simian Immunodeficiency Virus Differing in Infectivity and Cellular Tropism , 2007, Journal of Virology.
[8] D. Purcell,et al. Killing Kinetics of Simian Immunodeficiency Virus-Specific CD8+ T Cells: Implications for HIV Vaccine Strategies1 , 2007, The Journal of Immunology.
[9] R. Steinman,et al. Atraumatic Oral Spray Immunization with Replication-Deficient Viral Vector Vaccines , 2007, Journal of Virology.
[10] D. Burton,et al. Fc receptor but not complement binding is important in antibody protection against HIV , 2007, Nature.
[11] D. Watkins,et al. Molecular typing of major histocompatibility complex class I alleles in the Indian rhesus macaque which restrict SIV CD8+ T cell epitopes , 2007, Immunogenetics.
[12] M. Carrington,et al. Mamu-B*08-Positive Macaques Control Simian Immunodeficiency Virus Replication , 2007, Journal of Virology.
[13] Ryan D. Hernandez,et al. Demographic Histories and Patterns of Linkage Disequilibrium in Chinese and Indian Rhesus Macaques , 2007, Science.
[14] R. Desrosiers,et al. Induction of a virus-specific effector–memory CD4+ T cell response by attenuated SIV infection , 2006, The Journal of experimental medicine.
[15] B. Jia,et al. Single-cycle SIV: a novel AIDS vaccine approach , 2006 .
[16] D. O’Connor,et al. Control of Simian Immunodeficiency Virus SIVmac239 Is Not Predicted by Inheritance of Mamu-B*17-Containing Haplotypes , 2006, Journal of Virology.
[17] R. Steinman,et al. Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus. , 2006, Virology.
[18] Jiang Fan,et al. Vaccine-Induced Cellular Immune Responses Reduce Plasma Viral Concentrations after Repeated Low-Dose Challenge with Pathogenic Simian Immunodeficiency Virus SIVmac239 , 2006, Journal of Virology.
[19] D. Montefiori,et al. Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge , 2006, The Journal of experimental medicine.
[20] Gary J. Nabel,et al. Preserved CD4+ Central Memory T Cells and Survival in Vaccinated SIV-Challenged Monkeys , 2006, Science.
[21] M. Carrington,et al. The High-Frequency Major Histocompatibility Complex Class I Allele Mamu-B*17 Is Associated with Control of Simian Immunodeficiency Virus SIVmac239 Replication , 2006, Journal of Virology.
[22] J. Tartaglia,et al. Improved Vaccine Protection from Simian AIDS by the Addition of Nonstructural Simian Immunodeficiency Virus Genes1 , 2006, The Journal of Immunology.
[23] D. Watkins,et al. Attenuation of Simian Immunodeficiency Virus SIVmac239 Infection by Prophylactic Immunization with DNA and Recombinant Adenoviral Vaccine Vectors Expressing Gag , 2005, Journal of Virology.
[24] R. Desrosiers,et al. Virion Envelope Content, Infectivity, and Neutralization Sensitivity of Simian Immunodeficiency Virus , 2005, Journal of Virology.
[25] J. Lifson,et al. Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS , 2005, Journal of medical primatology.
[26] R. Desrosiers,et al. Immunization of Macaques with Single-Cycle Simian Immunodeficiency Virus (SIV) Stimulates Diverse Virus-Specific Immune Responses and Reduces Viral Loads after Challenge with SIVmac239 , 2005, Journal of Virology.
[27] R. Desrosiers,et al. Impact of Nef-Mediated Downregulation of Major Histocompatibility Complex Class I on Immune Response to Simian Immunodeficiency Virus , 2004, Journal of Virology.
[28] V. Maino,et al. Insufficient Production and Tissue Delivery of CD4+Memory T Cells in Rapidly Progressive Simian Immunodeficiency Virus Infection , 2004, The Journal of experimental medicine.
[29] R. Desrosiers,et al. A Novel Approach for Producing Lentiviruses That Are Limited to a Single Cycle of Infection , 2004, Journal of Virology.
[30] R. Doms,et al. Modulation of Env Content in Virions of Simian Immunodeficiency Virus: Correlation with Cell Surface Expression and Virion Infectivity , 2004, Journal of Virology.
[31] Takahiro Hirata,et al. Cytotoxic T Lymphocyte–based Control of Simian Immunodeficiency Virus Replication in a Preclinical AIDS Vaccine Trial , 2004, The Journal of experimental medicine.
[32] J. Lifson,et al. Optimization of intracellular cytokine staining for the quantitation of antigen-specific CD4+ T cell responses in rhesus macaques. , 2004, Journal of immunological methods.
[33] B. Walker,et al. Progress in Defining CD4 Helper Cell Responses in Chronic Viral Infections , 2003, The Journal of experimental medicine.
[34] D. Burton,et al. Assorted Mutations in the Envelope Gene of Simian Immunodeficiency Virus Lead to Loss of Neutralization Resistance against Antibodies Representing a Broad Spectrum of Specificities , 2003, Journal of Virology.
[35] J. Heeney,et al. Single-cycle immunodeficiency viruses provide strategies for uncoupling in vivo expression levels from viral replicative capacity and for mimicking live-attenuated SIV vaccines. , 2003, Virology.
[36] R. Means,et al. Determinants of Increased Replicative Capacity of Serially Passaged Simian Immunodeficiency Virus with nef Deleted in Rhesus Monkeys , 2003, Journal of Virology.
[37] Hao Shen,et al. Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory , 2003, Science.
[38] M. Bevan,et al. Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help , 2003, Science.
[39] Urs Christen,et al. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes , 2003, Nature.
[40] Todd M. Allen,et al. Expression of the Major Histocompatibility Complex Class I Molecule Mamu-A*01 Is Associated with Control of Simian Immunodeficiency Virus SIVmac239 Replication , 2003, Journal of Virology.
[41] J. Lifson,et al. SIVmac pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans , 2002, AIDS.
[42] D. Watkins,et al. Immunization of Rhesus Macaques with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen Induces Broad Simian Immunodeficiency Virus (SIV)-Specific T-Cell Responses and Reduces Initial Viral Replication but Does Not Prevent Disease Progression following Challenge with Pathogenic SIVmac239 , 2002, Journal of Virology.
[43] Peter J. Dailey,et al. The Liver Is a Major Organ for Clearing Simian Immunodeficiency Virus in Rhesus Monkeys , 2002, Journal of Virology.
[44] P. Earl,et al. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. , 2002, Vaccine.
[45] Z. Grossman,et al. HIV preferentially infects HIV-specific CD4+ T cells , 2002, Nature.
[46] E. Wherry,et al. Vaccines: Effector and memory T-cell differentiation: implications for vaccine development , 2002, Nature Reviews Immunology.
[47] John P. Moore,et al. AIDS vaccine models: Challenging challenge viruses , 2002, Nature Medicine.
[48] Henryk Mach,et al. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity , 2002, Nature.
[49] D. Lu,et al. Titration of an SIVmac251 stock by vaginal inoculation of Indian and Chinese origin rhesus macaques: transmission efficiency, viral loads, and antibody responses. , 2001, AIDS research and human retroviruses.
[50] David Montefiori,et al. An Effective AIDS Vaccine Based on Live Attenuated Vesicular Stomatitis Virus Recombinants , 2001, Cell.
[51] C. Cheng‐Mayer,et al. Antibody Protects Macaques against Vaginal Challenge with a Pathogenic R5 Simian/Human Immunodeficiency Virus at Serum Levels Giving Complete Neutralization In Vitro , 2001, Journal of Virology.
[52] Susan M. Kaech,et al. Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells , 2001, Nature Immunology.
[53] A. Roberts,et al. Glycoprotein Exchange Vectors Based on Vesicular Stomatitis Virus Allow Effective Boosting and Generation of Neutralizing Antibodies to a Primary Isolate of Human Immunodeficiency Virus Type 1 , 2000, Journal of Virology.
[54] A. Simon,et al. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. , 2000, Science.
[55] F. Kirchhoff,et al. Simian and Human Immunodeficiency Virus Nef Proteins Use Different Surfaces To Downregulate Class I Major Histocompatibility Complex Antigen Expression , 2000, Journal of Virology.
[56] T. Quinn,et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. , 2000, The New England journal of medicine.
[57] J. Mascola,et al. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies , 2000, Nature Medicine.
[58] Tahir A. Rizvi,et al. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian–human immunodeficiency virus infection , 2000, Nature Medicine.
[59] D. Montefiori,et al. Protection by Live, Attenuated Simian Immunodeficiency Virus against Heterologous Challenge , 1999, Journal of Virology.
[60] R. Johnson,et al. Characterization of SIV‐specific CD4 + T‐helper proliferative responses in macaques immunized with live‐attenuated SIV , 1999, Journal of medical primatology.
[61] C. Pitcher,et al. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression , 1999, Nature Medicine.
[62] Nancy Haigwood,et al. Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell–free virions from blood plasma , 1999, Nature Medicine.
[63] H. McClure,et al. Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques , 1999, Nature Medicine.
[64] Alan S. Perelson,et al. Rapid Clearance of Simian Immunodeficiency Virus Particles from Plasma of Rhesus Macaques , 1999, Journal of Virology.
[65] J. Altman,et al. Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function , 1998, The Journal of experimental medicine.
[66] J. Lifson,et al. Chemical inactivation of retroviral infectivity by targeting nucleocapsid protein zinc fingers: a candidate SIV vaccine. , 1998, AIDS research and human retroviruses.
[67] D. Ho,et al. Temporal Analyses of Virus Replication, Immune Responses, and Efficacy in Rhesus Macaques Immunized with a Live, Attenuated Simian Immunodeficiency Virus Vaccine , 1998, Journal of Virology.
[68] R. Means,et al. A role for carbohydrates in immune evasion in AIDS , 1998, Nature Medicine.
[69] Todd M. Allen,et al. Analysis of Gag-specific Cytotoxic T Lymphocytes in Simian Immunodeficiency Virus–infected Rhesus Monkeys by Cell Staining with a Tetrameric Major Histocompatibility Complex Class I–Peptide Complex , 1998, The Journal of experimental medicine.
[70] A S Perelson,et al. Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. , 1998, Science.
[71] B. Everitt,et al. Analysis of longitudinal data , 1998, British Journal of Psychiatry.
[72] R. Means,et al. Neutralization sensitivity of cell culture-passaged simian immunodeficiency virus , 1997, Journal of virology.
[73] R. Stebbings,et al. Mechanisms of protection induced by attenuated simian immunodeficiency virus. I. Protection cannot be transferred with immune serum. , 1997, The Journal of general virology.
[74] J. Robinson,et al. Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity , 1997, Journal of virology.
[75] D. Montefiori,et al. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus , 1996, Journal of virology.
[76] R. Bronson,et al. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. , 1995, Science.
[77] R. Ahmed,et al. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection , 1994, Journal of virology.
[78] R. Desrosiers,et al. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. , 1992, Science.
[79] R. Desrosiers,et al. Complex determinants of macrophage tropism in env of simian immunodeficiency virus , 1992, Journal of virology.
[80] Philip R. Johnson,et al. HIV vaccine design: insights from live attenuated SIV vaccines , 2005, Nature Immunology.
[81] S. Roth. One step forwards, one step backwards, one step forwards: the impact of EU policy on gender relations in Central and Eastern Europe , 2004 .
[82] Stellbrink et al. SIVmac pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans, , 2003 .
[83] R. Desrosiers,et al. Recombinant simian immunodeficiency virus expressing green fluorescent protein identifies infected cells in rhesus monkeys. , 1999, AIDS research and human retroviruses.
[84] R. Desrosiers,et al. Resistance of neonatal monkeys to live attenuated vaccine strains of simian immunodeficiency virus , 1997, Nature Medicine.
[85] B. Hill. The Institute of Laboratory Animal Resources. , 1961, Bio-medical purview.